Application no. and date | 03708130.4 (espacenet) (Federated) (European Patent Register), 20030225 | Patent/reg. no. and date | DK/EP 1482938, 20070808 | Publication date | 20041208 | Priority no. and date | EP 02004987, 20020306 | EP pub. no. and date |
EP 1482938 20041208 | Effective date | | Applicant/owner | Takeda GmbH, Byk-Gulden-Strasse 2
78467 Konstanz, DE | Applicant ref. no. | P42970DK01 | Inventor | WOLLIN, Stefan-Lutz, Lehrenweg 15/4
88709 Meersburg, DE, BEUME, Rolf, Bohlstrasse 13
78465 Konstanz, DE, WEIMAR, Christian, Helene und Maria Schiess-Str. 29
78467 Konstanz, DE, BUNDSCHUH, Daniela, im rank 5
CH-8272 Ermatingen, CH | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/4375 (2006.01) , A61K 31/4425 (2006.01) , A61K 31/4523 (2006.01) , A61K 45/06 (2006.01) , A61P 11/06 (2006.01) , A61P 11/08 (2006.01) | Title | Farmaceutisk præparat af en PDE4 eller en PDE3/4 inhibitor og en histaminreceptorantagonist | Int. application no. | EP2003001876 | Int. publication no. | WO2003074055 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|